Vaccine · 2026
Acute intraocular inflammation: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yeh Steven, Mathenge Wanjiku, Mwanza Jean-Claude, Shetty Supriya, Taylor Alice, Kaftan Timothy, Ali Hammad, Law Barbara
Аннотация
This is a new Brighton Collaboration (BC) case definition of acute intraocular inflammation (aIOI) which includes one or more of: anterior uveitis, intermediate uveitis, posterior uveitis, panuveitis, retinal vasculitis, and neuroretinitis. It is intended for use in vaccine safety studies including clinical trials throughout the vaccine life cycle, background incidence studies, causality assessment hypothesis testing studies and post-licensure pharmacovigilance activities to facilitate safety data comparability across multiple settings. It is not intended to guide clinical management. The case definition was developed by a group of subject matter and BC process experts as part of the Coalition for Epidemic Preparedness Innovations (CEPI) funded Safety Platform for Evaluation of vACcines (SPEAC). The BC case definition includes a scoping review of literature and expert consensus used to define levels of diagnostic certainty for aIOI and provide specific guidelines for related data collection and analysis. The document underwent peer review by vaccine safety stakeholders to ensure case definition usability and applicability as well as aIOI experts for scientific integrity.